Jefferies upgraded Marvell (NASDAQ: MRVL) from Hold to Buy with a price target of $27.00 (from $18.50).

Analyst Mark Lipacis believes the combination with CAVM generates a product portfolio with synergies and believes the deal creates better scale. The analyst believes there is a high probability the deal gets approval from regulatory agencies.

For an analyst ratings summary and ratings history on Marvell click here. For more ratings news on Marvell click here.

Shares of Marvell closed at $21.59 yesterday.

Analyst Comments Upgrades

Marvell Technology (MRVL) Climbs 8%, Adding to Recent GainsNovember 21, 2017 2:42 PM Marvell (MRVL) PT Raised to $25 at Northland Capital MarketsNovember 21, 2017 9:41 AM Marvell (MRVL) PT Raised to $30 at OppenheimerNovember 21, 2017 9:21 AM Cavium Networks (CAVM) PT Raised to $85 at Canaccord Genuity Following Announced Agreement with MarvellNovember 21, 2017 8:12 AM Marvell (MRVL) PT Raised to $25 at Needham & CompanyNovember 21, 2017 7:38 AM Cavium Networks (CAVM) PT Raised to $90 at Needham & Company, 'We See Further Upside in CAVM Shares'November 21, 2017 7:37 AM Marvell (MRVL) PT Raised to $34 at Craig-HallumNovember 21, 2017 7:35 AM Cavium Networks (CAVM) PT Raised to $90 at Needham & CompanyNovember 21, 2017 6:06 AM Loop Capital Downgrades Cavium Networks (CAVM) to Hold Following AcquisitionNovember 21, 2017 5:42 AM Morgan Stanley Downgrades Cavium Networks (CAVM) to Equalweight Following AcquisitionNovember 21, 2017 5:03 AM Barclays Upgrades Marvell (MRVL) to OverweightNovember 21, 2017 4:57 AM Jefferies Downgrades Cavium Networks (CAVM) to Hold Following The AcquisitionNovember 21, 2017 4:52 AM